Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Tracking Optical Coherence Tomography

This study has been completed.
Sponsor:
Collaborator:
National Eye Institute (NEI)
Information provided by (Responsible Party):
University of Pittsburgh
ClinicalTrials.gov Identifier:
NCT00343603
First received: June 19, 2006
Last updated: October 24, 2016
Last verified: July 2011
  Purpose
The purpose of this research study is to evaluate an investigational system that may allow doctors to show images of the different parts inside the eye that show greater detail than current equipment can produce.

Condition Phase
Macular Degeneration
Glaucoma
Diabetic Retinopathy
Choroidal Disease
Phase 2

Study Type: Observational
Official Title: Tracking Optical Coherence Tomography

Resource links provided by NLM:


Further study details as provided by University of Pittsburgh:

Enrollment: 100
Study Start Date: October 2004
Study Completion Date: January 2011
Primary Completion Date: December 2010 (Final data collection date for primary outcome measure)
Detailed Description:
The purpose of this research study is to evaluate an investigational system that may allow doctors to make images of the parts inside the eye that show greater detail than current equipment can produce.
  Eligibility

Ages Eligible for Study:   18 Years to 85 Years   (Adult, Senior)
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
Subject can range between 18 to 85 years old. They can be healthy or diseased. Recruiting males and females.
Criteria

Inclusion Criteria:

  • Healthy individuals (this includes women of child-bearing potential) who are familiar with vision experiments and ophthalmic equipment, all over 18 years.
  • Subjects will have a retinal screening if they are over 50 years old or have a known risk factor for eye disease, such as family history of age related macular degeneration or cardiovascular disease.
  • Patients with retinal and choroidal disease: age related maculopathy or age related macular degeneration, diabetic retinopathy, glaucoma.

Exclusion Criteria:

  • Over 85 years old
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00343603

Locations
United States, Pennsylvania
University of Pittsburgh
Pittsburgh, Pennsylvania, United States, 15213
Sponsors and Collaborators
University of Pittsburgh
National Eye Institute (NEI)
Investigators
Principal Investigator: Gadi Wollstein, MD University of Pittsburgh
  More Information

Responsible Party: University of Pittsburgh
ClinicalTrials.gov Identifier: NCT00343603     History of Changes
Other Study ID Numbers: 0309019  2R44EY013036 
Study First Received: June 19, 2006
Last Updated: October 24, 2016
Health Authority: United States: Institutional Review Board
Individual Participant Data  
Plan to Share IPD: Undecided

Keywords provided by University of Pittsburgh:
maculopathy

Additional relevant MeSH terms:
Macular Degeneration
Diabetic Retinopathy
Choroid Diseases
Retinal Degeneration
Retinal Diseases
Eye Diseases
Diabetic Angiopathies
Vascular Diseases
Cardiovascular Diseases
Diabetes Complications
Diabetes Mellitus
Endocrine System Diseases
Uveal Diseases

ClinicalTrials.gov processed this record on December 07, 2016